Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$2.2300
+0.0100 ( -0.45% ) 0.1K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$2.2300
Previous close
$2.2200
Volume
0.1K
Market cap
$125.62M
Day range
$2.1660 - $2.3750
52 week range
$2.0900 - $7.6600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 16, 2024 |
4 | Insider transactions | 1 | Dec 16, 2024 |
4 | Insider transactions | 1 | Dec 16, 2024 |
8-k | 8K-related | 15 | Nov 05, 2024 |
10-q | Quarterly Reports | 67 | Nov 05, 2024 |
8-k | 8K-related | 15 | Oct 07, 2024 |
8-k | 8K-related | 15 | Sep 23, 2024 |
4 | Insider transactions | 1 | Sep 20, 2024 |
4 | Insider transactions | 1 | Sep 20, 2024 |
4 | Insider transactions | 1 | Sep 20, 2024 |